GNMSF News and Press, Genmab A/S Dkk From 02/26/21

The following slide deck was published by Genmab A/S in conjunction with their 2020 Q4 earnings call. For further details see: Genmab A/S 2020 Q4 - Results - Earnings Call Presentation

Genmab A/S (GMAB) Q4 2020 Earnings Conference Call February 23, 2021, 12:00 ET Company Participants Jan van de Winkel - Co-Founder, President & CEO Anthony Pagano - EVP & CFO Anthony Mancini - EVP & COO Judith Klimovsky - EVP & Chief Development Officer Tahamtan Ahmadi - SVP C...

BMEZ delivered solid results throughout 2020, helped by the healthcare sector overall. This fund doesn't just invest in your typical healthcare companies though and tilts towards smaller and private investments. These companies are ripe for significant growth, at the same time, BM...

Halvorsen's 13F portfolio value increased from $23.14B to $27.68B. The number of positions increased 71 to 86. Viking Global increased Microsoft, Mecadolibre, and CME Group while reducing Amazon.com and dropping Uber Technologies & JD.com. The top three positions are Microsoft...

BioMarin is a leader in rare disease therapy discovery with multiple competitive advantages including scale, expertise, patents and relationships. Two major catalysts for 2021 provide investors with favorable risk/reward skew afforded by a low share price that should not be ignored. ...

BMEZ is a fund that is focused on the healthcare space, more specifically, a focus on the health sciences industry. They overlay this healthcare strategy with an option writing strategy to potentially enhance income. The fund has done exceptionally well since its launch right befo...

The following slide deck was published by Genmab A/S in conjunction with their 2020 Q3 earnings call. For further details see: Genmab A/S 2020 Q3 - Results - Earnings Call Presentation

Genmab A/S (GMAB) Q3 2020 Earnings Conference Call November 4, 2020 12:00 ET Company Participants Jan van de Winkel - President and Chief Executive Officer Anthony Pagano - Chief Financial Officer Judith Klimovsky - Chief Development Officer Anthony Mancini - Chief Operating Officer Conferenc...

NantKwest announces initiation of second generation COVID-19 vaccine candidate. Protagonist Therapeutics receives orphan drug status for PTG-300. Genmab reports positive data from Phase 2 CASSIOPEIA study. For further details see: NantKwest COVID-19 Candidate, And Other ...

This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen’s 13F stock portfolio on a quarterly basis. It is based on Viking Global’s regulatory 13F Form filed on 08/7/2020. Please visit our Tracking Ole Andreas Halvorsen&...